Massachusetts' Agenus (AGEN) to Phase Out 20% of Jobs, Shutter Switzerland Facility in Restructuring
Mass Layoffs Coming for Ariad (ARIA) Employees After Takeda (TKPYY)'s $5.2 Billion Buyout Deal
Tango Therapeutics Officially Debuts With $55 Million and a Crew of Superstar Scientific Advisers
Top 5 Life Science Jobs for Working from Home
Top Pros and Cons of Contract Work in the Life Sciences Industry
Interview Insider: Tips on How to Get Hired From Merck & Co. (MRK), Eli Lilly (LLY) and Pfizer (PFE)
3 Most Cash-Rich Drugmakers Right Now—But Pfizer (PFE) May Knock One Out of Its Ranking Soon
How to Find Hidden Lucrative Life Science Jobs in Government
Novartis AG (NVS) Jumps Into the Front of the CAR-T Line With Speedy Review of New Leukemia Drug
Tiny Massachusetts Phenom Corbus (CRBP)' CF Drug Delivers in Second Phase II Trial
This Game-Changing Drug Could be Regeneron (REGN)'s Next Blockbuster
What a Day! Genentech (RHHBY) Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis
Vertex (VRTX) Consolidating R&D Ops in 3 Locations, Shutters Site in Canada
Celgene (CELG) Stocks Up on More Juno (JUNO) Stock After Failed Flagship Drug Trial
And It Begins...President Trump Looks to Cut $1.2 Billion of NIH R&D Spending This Year
Bay Area's Depomed (DEPO) Craters as New CEO, Directors are Named in Deal With Activist Investor
Trump's FDA Head Nominee to Recuse Himself From Decisions Involving 20+ Companies
BioPharm Executive: Is There a New Approach to Drug Price Reform Brewing?
See All News >
3 Drugmakers With Boatloads Of Cash To Spend
Top Biotech Stocks For Growth Investors
The Senator From Ground Zero Of The Opioid Crisis Has No Idea What He's Talking About
Is Vertex (VRTX)'s New CF Drug Unprecedented? Incremental? Expensive? Maybe All Three
Toward Glow-In-The-Dark Tumors: New Fluorescent Probe Could Light Up Cancer, Michigan Tech Study Reveals
Tracking Hazardous Chemicals From Fast-Food Wrappers In The Body, University of Alabama at Birmingham Study
Researchers Control Soft Robots Using Magnetic Fields, North Carolina State University Study Reveals
AbbVie (ABBV)'s New Approach To Fighting Cancer At Their Roots
Regeneron (REGN)'s New Drug Price Could Disappoint Everyone. Here's Why That's A Good Thing
Uproar Ensues as Pfizer (PFE) Sends 58 Israeli Doctors to Conference Promoting Its Blood-Thinning Drug Eliquis
As Blockbuster Drugs Fizzle, Biotech Looks Warily To The Next Big Thing
To Translate Medical Science Effectively, Researchers Must Understand Commercialization
Why Catalyst Biosciences Nearly Tripled
An Old Drug With New Tricks: May Potentially Treat Spinal Cord Injuries, Purdue University Reveals
Senator Launches Investigation Into Top Opioid Makers—Purdue Pharma L.P., Janssen/Johnson & Johnson (JNJ), INSYS, Mylan (MYL) And Depomed (DEPO)
3 Top Medical Device Stocks To Buy In 2017
ConvaTec Investors Rake In $1.2 Billion Via Stake Sale
This Working Model Of The Female Reproductive System Can Fit In The Palm Of Your Hand, Northwestern University Feinberg School of Medicine Study Reveals
See All News >